SF
KYNB

Synovus Financial’s Kyntra Bio KYNB Stock Holding History

Synovus Financial’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3
Closed -$3K – 936
2020
Q2 		$3K Sell
3
-8
-73% -$7.43K ﹤0.01% 1388
2020
Q1 		$10K Buy
11
+8
+267% +$7.95K ﹤0.01% 1564
2019
Q4 		$3K Hold
3
– – ﹤0.01% 1370
2019
Q3 		$3K Hold
3
– – ﹤0.01% 1347
2019
Q2 		$4K Hold
3
– – ﹤0.01% 1247
2019
Q1 		$4K Hold
3
– – ﹤0.01% 1256
2018
Q4 		$4K Hold
3
– – ﹤0.01% 1224
2018
Q3 		$5K Buy
+3
New +$4.62K ﹤0.01% 1231

Other funds holding KYNB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Synovus Financial's KYNB Position: Q3 2020 in Review

Synovus Financial sold out of Kyntra Bio (KYNB) in Q3 2020, closing a stake of 3 shares — an estimated $3K sold.

Synovus Financial first reported a position in KYNB in Q3 2018 and held it in 8 quarters. The position peaked at $10K in Q1 2020. 208 funds tracked by Wall St. Rank hold KYNB as of Q3 2020.

  • Synovus Financial reported no remaining Kyntra Bio position as of Q3 2020 after selling out during the quarter.
  • Synovus Financial sold 3 Kyntra Bio shares in Q3 2020, an estimated $3K.
  • Synovus Financial first reported a position in Kyntra Bio in Q3 2018 and held it in 8 quarters.
  • Synovus Financial's Kyntra Bio position peaked at $10K in Q1 2020.
  • 208 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2020.

Based on Synovus Financial's 13F filing for Q3 2020, filed 9 Nov 2020.